NCT05184348View on ClinicalTrials.gov

Plexin B2 Gene Expression and Polymorphisms in Psoriasis

PHASE1CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

January 30, 2023

Study Completion Date

March 30, 2023

Conditions
Psoriasis Vulgaris
Interventions
RADIATION

Narrow band Ultraviolet B phototherapy group

3 sessions weekly for 3 months with maximum dose 1400 mJ/cm2.

DRUG

Acitretin group

dose of 0.5-1 mg per kg per day orally for 3 month.

COMBINATION_PRODUCT

Acitretin plus Narrow band Ultraviolet B phototherapy group

Acitretin in dose of 0.5-1 mg per kg per day orally plus Narrow band Ultraviolet B phototherapy 3 sessions weekly for 3 months with maximum dose 1400 mJ/cm2.

Trial Locations (1)

Unknown

Faculty of Medicine , South Valley University, Qina

All Listed Sponsors
lead

South Valley University

OTHER

NCT05184348 - Plexin B2 Gene Expression and Polymorphisms in Psoriasis | Biotech Hunter | Biotech Hunter